August 7, 2024 – Page 5 – Goldea Capital

Iterum Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024

Written by Customer Service on August 7, 2024. Posted in Public Companies.

DUBLIN and CHICAGO, Aug. 07, 2024 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that the Company will release its second quarter 2024 financial results before the open of the U.S. financial markets on Wednesday, August 14, 2024. Management will host a conference call at 8:30 a.m. ET that day to discuss the Company’s financial results and provide an update on its business. To access the call please dial 833-470-1428 (domestic) or 404-975-4839 (international) and refer to Access Code 775539. To pre-register for this call, please go to the following link: . The audio webcast can be accessed...

Fiverr Releases its 2023 Environmental, Social and Governance (ESG) Report

Written by Customer Service on August 7, 2024. Posted in Public Companies.

Fiverr Releases its 2023 Environmental, Social and Governance (ESG) Report Fiverr Releases its 2023 Environmental, Social and Governance (ESG) Report NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) — Fiverr International Ltd. (NYSE: FVRR), the company that is changing how the world works together, released its 2023 Environmental, Social and Governance (ESG) report, detailing the actions taken in 2023 to ensure a more sustainable future and introducing new goals that are aligned with Fiverr’s key pillars and overall mission. Fiverr’s efforts around sustainability are an extension of the company’s core values and its culture of empowerment. Additionally, the company has aligned itself with six of the United Nations Sustainable Development Goals towards which its actions and initiatives can have the greatest impact: Quality Education;...

Genco Shipping & Trading Limited Announces Q2 2024 Financial Results

Written by Customer Service on August 7, 2024. Posted in Earnings Releases And Operating Results.

Declares Dividend of $0.34 per share for Q2 2024; Represents Genco’s 20th Consecutive Quarterly Dividend Totaling $5.915 Per Share NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) — Genco Shipping & Trading Limited (NYSE:GNK) (“Genco” or the “Company”), the largest U.S. headquartered drybulk shipowner focused on the global transportation of commodities, today reported its financial results for the three months and six months ended June 30, 2024. Second Quarter 2024 and Year-to-Date Highlights Dividend: Declared a $0.34 per share dividend for Q2 2024 20th consecutive quarterly dividend over the last five years Cumulative dividends of $5.915 per share or 33% of our share price1 Q2 2024 dividend is payable on or about August 26, 2024 to all shareholders of record as of August 19, 2024. Financial performance: Net income of $23.5 million...

Wilmington Announces 2024 Second Quarter Results

Written by Customer Service on August 7, 2024. Posted in Earnings Releases And Operating Results.

CALGARY, Alberta, Aug. 07, 2024 (GLOBE NEWSWIRE) — Wilmington Capital Management Inc. (“Wilmington” or the “Corporation”) reported a net loss for the three months ended June 30, 2024, of ($0.1) million or ($0.01) per share and net income for the six months ended June 30, 2024, of $1.1 million or $0.08 per share. compared to net income of $0.7 million or $0.06 per share and $0.1 million and $0.01 per share for the same periods in 2023. A summary of the Corporation’s activities and the operations of its investees is set out below: OverviewDuring the past 12 months the Corporation has monetized a number of its investments in order to unlock the embedded value, which had been substantially realized, simplify its business, repatriate capital to its shareholders and pursue transactions better suited to a changing economic environment. On...

NL INDUSTRIES ANNOUNCES A SPECIAL DIVIDEND OF 43 CENTS PER SHARE PAYABLE IN AUGUST 2024, AND A QUARTERLY DIVIDEND FOR THE THIRD QUARTER OF 2024 AT 8 CENTS PER SHARE

Written by Customer Service on August 7, 2024. Posted in Dividend Reports And Estimates.

Dallas, Texas, Aug. 07, 2024 (GLOBE NEWSWIRE) — NL Industries, Inc. (NYSE: NL) today announced that its board of directors has declared a special cash dividend of forty-three cents ($0.43) per share and a quarterly dividend of eight cents ($0.08) per share, in each case on its common stock. The special dividend, which is being funded from excess cash flows, is payable on August 29, 2024 to shareholders of record at the close of business on August 19, 2024. The quarterly dividend of $.08 per share is payable on September 24, 2024 to shareholders of record at the close of business on September 6, 2024. NL Industries, Inc. is engaged in the component products (security products and recreational marine components) and chemicals (TiO2) businesses. * * * * * Investor Relations Contact Bryan A. HanleySenior Vice President and TreasurerTel....

NL REPORTS SECOND QUARTER 2024 RESULTS

Written by Customer Service on August 7, 2024. Posted in Earnings Releases And Operating Results.

Dallas, Texas, Aug. 07, 2024 (GLOBE NEWSWIRE) — NL Industries, Inc. (NYSE: NL) today reported net income attributable to NL stockholders of $7.9 million, or $.16 per share, in the second quarter of 2024 compared to a net loss attributable to NL stockholders of $3.1 million, or $.06 per share, in the second quarter of 2023. NL results include an unrealized gain of $.8 million in the second quarter of 2024 related to the change in value of marketable equity securities compared to an unrealized loss of $5.4 million in the second quarter of 2023. For the first six months of 2024, NL reported net income attributable to NL stockholders of $14.7 million, or $.30 per share, compared to a net loss attributable to NL stockholders of $9.8 million, or $.20 per share for the first six months of 2023. NL results include an unrealized gain of...

Context Therapeutics Reports Second Quarter 2024 Operating and Financial Results

Written by Customer Service on August 7, 2024. Posted in Earnings Releases And Operating Results.

Announced acquisition of CT-95, a mesothelin x CD3 bispecific antibody Claudio Dansky Ullmann, M.D. named Chief Medical Officer Cash and cash equivalents of $101.5 million as of June 30, 2024 PHILADELPHIA, Aug. 07, 2024 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing medicines for solid tumors, today announced its financial results for the second quarter ended June 30, 2024, and reported on recent business highlights. “Context continues to build momentum, and we believe the Company is well positioned to have a successful year,” said Martin Lehr, CEO of Context. “Our team recently initiated our Phase 1 trial for CTIM-76, a Claudin 6 x CD3 bispecific antibody and looks forward to dosing our first patient in the third quarter. In addition, the recent acquisition...

Occidental Announces Second Quarter 2024 Results

Written by Customer Service on August 7, 2024. Posted in Earnings Releases And Operating Results.

HOUSTON, Aug. 07, 2024 (GLOBE NEWSWIRE) — Occidental (NYSE: OXY) today announced its second quarter 2024 financial results. The earnings release and accompanying financial schedules can be accessed via the Investor Relations section of the company’s website, oxy.com. The earnings release is also available on the U.S. Securities and Exchange Commission’s website at sec.gov. The company will hold a conference call to discuss the results on Thursday, August 8, 2024, at 1 p.m. Eastern/12 p.m. Central. The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at oxy.com/investors. Participants may pre-register for the conference call at https://dpregister.com/sreg/10189702/fca6e74d6e. A recording of the webcast will be posted on the Investor Relations section of the company’s...

KRONOS WORLDWIDE, INC. REPORTS SECOND QUARTER 2024 RESULTS

Written by Customer Service on August 7, 2024. Posted in Earnings Releases And Operating Results.

Dallas, TX, Aug. 07, 2024 (GLOBE NEWSWIRE) — Kronos Worldwide, Inc. (NYSE:KRO) today reported net income of $19.5 million, or $.17 per share, in the second quarter of 2024 compared to a net loss of $8.2 million, or $.07 per share, in the second quarter of 2023. For the first six months of 2024, Kronos Worldwide reported net income of $27.6 million, or $.24 per share, compared to a net loss of $23.4 million, or $.20 per share, in the first six months of 2023. Net income increased in the 2024 periods as compared to the same periods in 2023 primarily due to higher income from operations as a result of the effects of higher sales and production volumes, lower production costs (primarily energy and raw materials), partially offset by lower average TiO2 selling prices. Our results of operations in the first six months of 2023 were significantly...

CoreCivic Reports Second Quarter 2024 Financial Results

Written by Customer Service on August 7, 2024. Posted in Earnings Releases And Operating Results.

Higher Occupancy and Cost Management Initiatives Drive PositiveQuarterly Financial Performance BRENTWOOD, Tenn., Aug. 07, 2024 (GLOBE NEWSWIRE) — CoreCivic, Inc. (NYSE: CXW) (CoreCivic or the Company) announced today its second quarter 2024 financial results. Financial Highlights – Second Quarter 2024 Total revenue of $490.1 million CoreCivic Safety revenue of $455.4 million CoreCivic Community revenue of $30.3 million CoreCivic Properties revenue of $4.4 million Net income of $19.0 million; Adjusted Net Income of $21.8 million Diluted earnings per share of $0.17; Adjusted Diluted EPS of $0.20 Normalized FFO per diluted share of $0.42, an increase of 27% Adjusted EBITDA of $83.9 million, an increase of 16% Damon T. Hininger, CoreCivic’s President and Chief Executive Officer, commented, “CoreCivic carried its...

Day: August 7, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice